Chunlizhengda Medical Instruments
Chunlizhengda Medical Instruments (Beijing Chunli Zhengda, est. 1998, A+H listed) is a Chinese manufacturer of orthopedic and dental implants, surgical robots and biomaterials — including the world's first handheld hip arthroplasty robot — selling to 6,000+ hospitals in China and 50+ countries.
- Company typePublic
- Founded1998
- HeadquartersTongzhou, China
- Headcount1,001–5,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What Chunlizhengda Medical Instruments does
Beijing Chunli Zhengda Medical Instrument Co., Ltd. (Chunlizhengda Medical Instruments; A-share 688236.SH, H-share 01858.HK), founded in 1998 by Shi Chunbao and headquartered in Tongzhou District, Beijing, designs, develops, manufactures and markets orthopedic implants, surgical robots and dental medical devices for hospitals and specialty clinics. Its product portfolio spans surgical robots (the Yangtze INS-1 handheld hip robot, Yellow River INS-1 handheld knee robot, and a handheld unicompartmental knee robot), joint prostheses (including the NMPA-approved Biological Total Knee Prosthesis with dual Ti+HA coating, rotating-hinge and modular knee systems, total acetabular cups, reverse shoulder, patellofemoral and toe prostheses), spinal implants (porous tantalum interbody cages, self-stabilizing ALIF cages, non-fusion spinous-process implants, titanium cables, 3D-printed lamina plates), sports-medicine devices (tantalum-coated suture anchors, 3D-printed titanium alloy anchors, magnesium-alloy platform in development), trauma and cranioplasty systems, the Battery-Powered Bone Tissue Surgical Device (via subsidiary Shujie Medical), a Full-Automatic PRP Preparation Kit, and an oral-care line (dental implants, self-ligating brackets, orthodontic mini-implants, light-cured resins and glass-ionomer cements). Core technical differentiators include dual vacuum/atmospheric plasma-sprayed Ti+HA bioactive coatings, porous tantalum via CVD, biphasic calcium-phosphate ceramics, magnesium-alloy biomaterials, and AI-enabled CT-based surgical planning and navigation with sub-millimeter positional accuracy.
The company operates a B2B hardware-sales model, selling implantable devices, surgical robots and PRP systems directly to 6,000+ hospitals across China and via distributors to 50+ (one source: 70+) countries in Asia, Africa, Europe and the Americas, with CE marking on hip/knee/spine lines and US FDA 510(K) clearance for the Knee Joint Prosthesis System. Commercial reach is built through flagship orthopedic and dental congresses (AAOS, COA, CSSM, MEDICA, Arab Health, Dental South China), academic-exchange symposia, online surgery livestreams, and a dedicated 'CIJR Academy' training portal. Pricing is quote-based and not publicly disclosed; international expansion is supported by the Clover Medical handheld robotic system, with the first overseas deployments in Türkiye (June 2025) and the AAOS 2026 debut in New Orleans (March 2026). The company has 1,000+ employees, 215 NMPA medical-device registration certificates, 1,172 authorized + pending patents, and holds national-level recognitions including 'Manufacturing Single Champion Enterprise' (MIIT, 2024) and 'Little Giant' status, with the chairman role currently held by Shi Wenling.
Chunlizhengda Medical Instruments firmographics
Firmographics- Name
- Chunlizhengda Medical Instruments
- Legal name
- Beijing Chunli Zhengda Medical Instrument Co., Ltd. (北京市春立正达医疗器械股份有限公司)
- Website
- https://clzd.com
- Company type
- Public
- Founded year
- 1998
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- Chunlizhengda Medical Instruments (Beijing Chunli Zhengda, est. 1998, A+H listed) is a Chinese manufacturer of orthopedic and dental implants, surgical robots and biomaterials — including the world's first handheld hip arthroplasty robot — selling to 6,000+ hospitals in China and 50+ countries.
- Ownership category
- akta.pro rank
Chunlizhengda Medical Instruments industry classification
Industry- Product category
- Orthopedic Medical Devices
- NAICS
- Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113), Dental Equipment and Supplies Manufacturing (339114)
- SIC
- Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841), Dental Equipment & Supplies (3843)
- akta.pro primary industry
- Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle) (HLAHAEAA)
- akta.pro secondary industries
- Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine) (HLAHAEAL), Medical & Dental 3D Printing Services (patient-specific devices, dental labs) (IMAAADAG)
Keywords
Where Chunlizhengda Medical Instruments is headquartered
LocationHeadquarters
- HQ city
- Tongzhou
- HQ country
- China
- HQ region
- Asia
Offices2 records
Markets served
Chunlizhengda Medical Instruments business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure
Revenue model
- Orthopedic Implant & Medical Device Sales: One-time sale of implantable orthopedic devices (joint prostheses, spinal fixation systems, trauma, sports medicine, dental implants), PRP kits, surgical instruments, and orthopedic surgical robots to hospitals and clinics — by far the dominant revenue stream; products distributed to 6,000+ hospitals in China and 50+–70+ countries internationally.
- Channel / Distributor Sales: Revenue generated via authorized distributors and channel partners for dental product lines and select orthopedic lines, formalized through distributor signing ceremonies and a nationwide oral-care service-network expansion.
Go-to-market motion1 record
Distribution channels4 records
Marketing channels10 records
Chunlizhengda Medical Instruments product offering
Product offeringCore offering
Chunlizhengda Medical Instruments (Beijing Chunli Zhengda Medical Instrument Co., Ltd.) designs, develops, manufactures and markets a comprehensive portfolio of patented orthopedic implants (joint prostheses, spinal fixation, sports medicine, trauma), dental implants and orthodontic/restorative materials, orthopedic power instruments, PRP preparation systems, and handheld robotic-assisted surgical systems. Its products are sold to 6,000+ hospitals in China and exported to 50+–70+ countries worldwide, supported by FDA 510(K) clearance for the Knee Joint Prosthesis System and CE marking for hip, knee, and spinal lines.
Product overview
Chunlizhengda Medical Instruments (Beijing Chunli Zhengda Medical Instrument Co., Ltd., founded 1998) operates as a single integrated orthopedic and dental implant platform with multiple product modules rather than a unified SaaS-style product. Its portfolio spans (1) Surgical Robots — Yangtze INS-1 handheld hip robot, Yellow River INS-1 handheld knee robot, handheld unicompartmental knee robot, and the integrated Hip and Knee Arthroplasty Navigation System; (2) Joint Implants — including the Clover Biotype Biological Total Knee Prosthesis (NMPA Guo Xie Zhu Zhun 20253130823), Rotating Hinge Knee Prosthesis, Modular Knee Prosthesis, Unicompartmental Knee Prosthesis, Reverse Shoulder Arthroplasty, Patellofemoral Joint Prosthesis, Total Acetabular Cup, Femoral Head Reconstruction Rod, Toe Joint Prosthesis, and Hip Joint Acetabular Component; (3) Spinal Implants — Porous Tantalum Interbody Fusion Cage (CVD), 3D-Printed Spinal Lamina Fixation Plate System, Self-Stabilizing Interbody Fusion Cage, Non-Fusion Spinous Process Implant, and Spinal Titanium Cable; (4) Sports Medicine — Tantalum Coated Suture Anchor, 3D Printed Titanium Alloy Anchor, and the recently co-developed magnesium alloy sports medicine product line; (5) Orthopedic Power — the Battery-Powered Bone Tissue Surgical Device; (6) Cranial — Titanium Mesh Plate System; (7) PRP — the Full-Automatic Platelet-Rich Plasma Preparation Kit; and (8) Oral Care — Aesth SG One-Stage Ultra-Narrow Dental Implant, Vital HP Dental Implant, Orthodontic Mini-Implant, Self-Ligating Brackets, Light-cured Glass Ionomer Cement, Light-Curing Flowable Resin, and Dental Polymer-based Composite Resin. The surgical robots are explicitly designed to interoperate with the joint implant portfolio (e.g., the handheld robotic system enables precise cementless biological knee implantation), and the company is the only domestic enterprise widely applying tantalum metal across dental, joint, spinal, and sports medicine products.
Differentiator
Problem solved
Functional benefit
Brands
- Chunli Medical (春立医疗): Primary trade name for the publicly listed orthopedic and dental medical device manufacturer, used across product lines, news, and corporate communications.
Products and services
- Yangtze INS-1 Handheld Robotic System for Hip Replacement World's first handheld hip arthroplasty robot providing preoperative intelligent planning, intraoperative real-time navigation, and precise safety boundary control. Achieves sub-millimeter positional accuracy (positional deviation <1 mm, angular error <1°). For hospital orthopedic departments performing hip replacement surgery.
- Yellow River INS-1 Handheld Robotic System for Knee Replacement Nationally first handheld knee arthroplasty robot integrating CT segmentation modeling, intelligent planning, real-time navigation, and precise execution. Used clinically for total knee arthroplasty with cementless biological prostheses.
- Handheld Unicompartmental Knee Arthroplasty Robot Nationally first handheld robotic system dedicated to unicompartmental (partial) knee arthroplasty, with intelligent planning and boundary control. For hospital orthopedic departments performing partial knee replacement surgery.
- Biological Total Knee Prosthesis (Clover Biotype Total Knee System) Domestic-first dual-coated cementless total knee prosthesis with Ti+HA composite bioactive coating (vacuum plasma-sprayed titanium plus atmospheric plasma-sprayed hydroxyapatite), vitamin E-enhanced HXLPE tibial insert, gradient radius femoral condyle, and PS/CR variants. For hospital orthopedic departments performing total knee arthroplasty.
- Self-Stabilizing Interbody Fusion Cage NMPA-approved lumbar anterior self-stabilizing interbody fusion cage — hollow rectangular fusion device on a titanium alloy plate with tantalum markers for ALIF procedures, available in multiple heights, surface areas, and lordotic angles. For hospital spinal surgery departments.
- Non-Fusion Spinous Process Implant (Lumbar) Dynamic stabilization implant consisting of a U-shaped groove and four plate-shaped fixation devices made of TC4 titanium alloy for skeletally mature patients with grade 1 or 2 lumbar spinal stenosis between L1 and L5. For hospital spinal surgery departments.
- Spinal Titanium Cable NMPA-approved high-strength titanium cable composed of 49 strands in 7 bundles of 7 strands with a single-headed fixation clip offering 20° adjustable range, for sublaminar and interspinous fixation in C1–C7 cervical spine surgery.
- Titanium Mesh Plate System (Cranial Repair) NMPA-approved cranioplasty system composed of TA3G pure titanium mesh and TC4 titanium alloy fixation screws (including 2D and 3D meshes) for repairing cranial defects caused by trauma, surgery, or other causes. For hospital neurosurgery departments.
- Battery-Powered Bone Tissue Surgical Device NMPA-approved high-precision battery-driven orthopedic power tool from subsidiary Shujie Medical — German brushless motor with dual-speed 12,000/10,000 cpm, 4000 mAh lithium battery, convertible to sternal saw, and compatible with saw blades of internationally renowned brands. For hospital orthopedic and trauma surgery departments.
- Full-Automatic Platelet-Rich Plasma (PRP) Preparation Kit Fully automated device for preparing autologous PRP from human blood using optical-sensor-driven layer monitoring and patented horizontal centrifugation (Patent No. CN201810007371.0); ~84% platelet recovery rate, 15-minute cycle, adjustable PRP volume 3–10 mL and blood collection 30–60 mL. For hospital orthopedic, sports-medicine, dental, and maxillofacial departments.
- Orthodontic Mini-Implant (Anchor Screw) NMPA-approved titanium alloy orthodontic anchor screw with smooth round head cap, two ligature holes, inverted conical neck, self-tapping cutting tip, deep thread design, and anodized surface for wear and corrosion resistance. For hospital orthodontic departments and dental clinics.
- Chunli Aesth SG 'One-Stage Ultra-Narrow' Dental Implant
Quantifiable outcome
- Prosthetic implantation angular error <1° and positional deviation <1 mm during robotic-assisted hip/knee replacement in Turkey (surpassing traditional surgery precision)
- +2 more outcomes
Companies that use Chunlizhengda Medical Instruments
Customer profileNamed customers9 records
Segments4 records
Ideal customer profiles4 records
Chunlizhengda Medical Instruments technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability8 records
Feature11 records
Chunlizhengda Medical Instruments partnerships and signals
Strategic signalPartnerships
15 partnerships are on record, tiered minor, flagship, flagship (middle east), core, flagship (international robotic-system debut) and core (wholly-owned subsidiary).
- Liuyang Orthopedic-Traumatology Hospital (Hunan)minorHosted the 'Chunli Ortho Academic Exchange Symposium — Liuyang Stop' on March 21, 2026 (co-organized by Chunli). Combined theory lectures, surgical demonstrations and interactive discussions on arthroscopic shoulder/knee and ankle procedures.
- Ningbo Medical Center Lihuili HospitalflagshipCo-established the Zhejiang Provincial Engineering Research Center for Innovative Sports Medicine Technologies and Biomaterials. Joint research on magnesium-alloy sports-medicine products and clinical validation; co-hosted sports-medicine surgical continuing-education classes; led by Peng Zhaoxiang and Zheng Minzhe (Lihuili) and Du Jianwei (Chunli Sports-Medicine Product Line Operating Director).
- International Medical Center (IMC), Egyptflagship (middle east)Partner hospital hosting a one-week high-end orthopedic clinical-exchange visit by Professor George (former Greek Hip Society President) starting December 19, 2025. Focus on complex primary hip/knee replacement and revision surgeries; positions Chunli as a bridge for orthopedic medical-education exchange between China and North Africa.
- Professor Zhou Yonggang (Chinese PLA General Hospital, Orthopedics)coreCo-developed the world's first 'Adjustable Abduction-Angle and Anteversion-Angle Dual-Diameter Eccentric Jumbo Cup' for acetabular revision; presented at COA 2025 Innovation & Translation session. Two national invention patents granted (ZL 2020 1 1619511.3 and ZL 2021 1 0198519.5). Design based on 300-volunteer acetabular CT anatomical measurement data and FEA/biomechanical testing.
- Cangzhou Integrated Traditional Chinese and Western Medicine Hospital (Hebei Province)coreHost site for the China-Turkey academic exchange on September 18, 2025; presented Chunli Medical robotic-surgery, unicompartmental-knee and hip/knee surgical demonstrations; Turkish experts toured the hospital and observed TCM acupuncture treatments.
- Yulin Orthopedic Hospital of Integrated Traditional Chinese and Western MedicinecoreCo-built the AI-assisted diagnosis and treatment exhibition zone at the 2025 15th Yulin TCM Expo, jointly developing and showcasing the AI hip-and-knee joint replacement surgical-navigation robot system (a new-concept joint replacement surgical robot). Demonstrated to visiting officials including Wang Chen (Yulin Municipal Party Secretary).
- Bazhou Central Hospital & North China University of Science and Technology Affiliated Hospital (Hebei)coreHost sites for China-Russia-Kazakhstan academic exchange (June 29, 2025). Demonstrated XN total knee replacement, XK unicompartmental knee replacement, and three DAMIS (Direct Anterior Minimally Invasive Surgery) hip-replacement teaching cases led by Liang Junsheng.
- Gülhane Training and Research Hospital & Kırıkkale University Hospital (Türkiye)flagship (international robotic-system debut)First overseas deployment site of Clover Medical's Yangtze INS-1 handheld hip robot and Yellow River INS-1 handheld knee robot. Dr. Ugur Tiftikci and team performed 4 hip replacement and 2 knee replacement surgeries; achieved angular error <1° and positional deviation <1 mm.
- Harbin No.5 HospitalcoreHosted a delegation of Egyptian physicians for hospital tour, joint-replacement and sports-medicine knee-arthroscopy surgery observation. Led by Director Lü Songcen (Chairman of Heilongjiang Medical Association Orthopedics Committee) and President Fang Yuli. Strengthens Chunli's international clinical-collaboration footprint.
- Professor Ugur Tiftikci (Renowned Turkish Orthopedic Surgeon)coreLead surgeon for the first overseas deployment of Clover Medical handheld robotic systems in Türkiye; conducted 4 hip and 2 knee replacement surgeries with sub-millimeter precision; serves as clinical KOL for Clover Medical's internationalization strategy.
- Peking University Stomatology Hospital (Dr. Jin Chanyuan)minorSigned a cooperation agreement on biomaterial-based bone defect repair technology development with Chunli Dental. Lecturer Dr. Jin Chanyuan presented 'Post and Core Crown Restoration.'
- United Family Healthcare Group (Professor Dong Yu)minorSigned an agreement with Chief Engineer Xu Kuixue to launch an implantation new-technology development project. Lecturer Professor Dong Yu presented 'Timing and Clinical Procedures for Implant Restoration in the Esthetic Zone.'
- Stomatological Hospital of Guangdong ProvinceflagshipSigned a strategic cooperation agreement on March 3, 2025 at Dental South China (Founder Shi Chunbao and President Shao Longquan signing for both parties). Covers industry-university-research-medical collaborative innovation in oral product R&D and clinical technology transformation; positioned as a major milestone for high-end domestic oral medical technology.
- Tangdu Hospital of the Fourth Military Medical University (Dr. Zeng Guang)minorSigned a cooperation agreement on orthodontic product technology development with Chunli Dental's Chief R&D Engineer Xu Kuixue at Dental South China 2025. Lecturer Dr. Zeng Guang presented 'Establishment of Orthodontic Thinking for General Practitioners.'
- Shujie Medical Technology (Suzhou) Co., Ltd.core (wholly-owned subsidiary)Shujie Medical (founded 2013) was acquired by Chunli Medical in 2023 and operates as a wholly-owned subsidiary. It develops premium medical electric tools including the Battery-Powered Bone Tissue Surgical Device (with German superconducting brushless motor technology) and contributes to Chunli's orthopedic power-systems product line.
Scale indicators9 records
Recent moves7 records
Expansion highlights6 records
Chunlizhengda Medical Instruments competitors and assessment
Company assessmentDirect peers
- Stryker: Global orthopedic implants + Mako robotic-arm assisted surgery platform. Most direct competitor to Chunli's hip/knee implant + handheld robotic system internationally.
- Zimmer Biomet: Orthopedic joint reconstruction and ROSA robotic platform; competes with Chunli in hip/knee implants and surgical navigation, including in international tenders.
- Smith+Nephew: Orthopedic reconstruction, sports medicine and trauma — overlaps with Chunli's joint, sports-medicine and trauma lines, and offers the CORI handheld surgical robot.
- Globus Medical: Spine and orthopedic robotics company (ExcelsiusGPS); comparable to Chunli in spinal implants and as a robotic-navigation peer in international tenders.
- MicroPort Orthopedics: Chinese orthopedic implant company (MicroPort Scientific subsidiary) competing head-to-head with Chunli in joint prostheses and increasingly in surgical robotics domestically.
- AK Medical Holdings: Hong Kong-listed Chinese orthopedic implant peer with a comparable hip/knee/spine portfolio; closest like-for-like domestic comp for product mix, scale and regulatory positioning.
- Weigao Orthopedic: Shandong Weigao Group's orthopedic implant business — a major domestic Chinese competitor in joint and spine implants with broad hospital coverage.
Broad incumbents
- Medtronic: Spinal implants, surgical navigation/robotics (Mazor, Hugo) and a broad medtech portfolio; overlaps with Chunli's spine franchise and surgical-robot roadmap.
- Johnson & Johnson (DePuy Synthes): Broad incumbent in orthopedics, spine and trauma via DePuy Synthes; a direct competitor in hip/knee implants and spine, with much greater scale and global distribution.
Emerging players
- Align Technology: Global clear-aligner and iTero dental-imaging leader; comparable to Chunli's growing dental/orthodontic platform in target customer (dental hospitals/clinics) and digital workflow.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks5 records
Key highlights7 records
Customer concentration
Chunlizhengda Medical Instruments compliance and trust
Trust signalCompliance10 records
Chunlizhengda Medical Instruments financial estimates
Financial estimateRevenue estimate
Valuation estimate
Chunlizhengda Medical Instruments leadership team
Management profileNumber of profiles
Profiles5 records
Chunlizhengda Medical Instruments subsidiaries and ownership
Company hierarchySubsidiaries1 record
Chunlizhengda Medical Instruments funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Chunlizhengda Medical Instruments M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Chunlizhengda Medical Instruments
What does Chunlizhengda Medical Instruments do?
Chunlizhengda Medical Instruments (Beijing Chunli Zhengda Medical Instrument Co., Ltd.) designs, develops, manufactures and markets a comprehensive portfolio of patented orthopedic implants (joint prostheses, spinal fixation, sports medicine, trauma), dental implants and orthodontic/restorative materials, orthopedic power instruments, PRP preparation systems, and handheld robotic-assisted surgical systems. Its products are sold to 6,000+ hospitals in China and exported to 50+–70+ countries worldwide, supported by FDA 510(K) clearance for the Knee Joint Prosthesis System and CE marking for hip, knee, and spinal lines.
Is Chunlizhengda Medical Instruments a public or private company?
Chunlizhengda Medical Instruments is a public company. It is classified as public and is currently operating.
When was Chunlizhengda Medical Instruments founded?
Chunlizhengda Medical Instruments was founded in 1998. It employs 1,001 to 5,000 people.
Where is Chunlizhengda Medical Instruments based?
Chunlizhengda Medical Instruments is headquartered in Tongzhou, China, in the Asia region.
How does Chunlizhengda Medical Instruments make money?
Two revenue lines are on record. Orthopedic Implant & Medical Device Sales are the primary driver. The others are channel / Distributor Sales.
Who are Chunlizhengda Medical Instruments's main competitors?
Direct peers on record are Stryker, Zimmer Biomet, Smith+Nephew, Globus Medical, MicroPort Orthopedics, AK Medical Holdings and Weigao Orthopedic. Broad incumbents are Medtronic and Johnson & Johnson (DePuy Synthes). Align Technology is listed as an emerging player.
Does Chunlizhengda Medical Instruments have an API?
No public API is recorded for Chunlizhengda Medical Instruments.
What industry is Chunlizhengda Medical Instruments in?
Chunlizhengda Medical Instruments's product category is Orthopedic Medical Devices. Its primary akta.pro industry code is HLAHAEAA, Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle), with a secondary code of HLAHAEAL, Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine). Its NAICS code is 339112 and its SIC code is 3842.